Forma Medical Announces Strategic Focus on OptimalMTP™, Issuance of Key Methods Patent, and Appointment of Aaron Smith to Board of Directors
Forma Medical Inc. announced a sharpened strategic focus on OptimalMTP™, a procedural innovation enabling minimally invasive plating of first metatarsophalangeal (MTP) joint fusion, along with the issuance of a key methods patent and the appointment of Aaron Smith, former CEO of Artelon, to its Board of Directors.
Forma Medical Expands MIS Portfolio; Adds OptimalTMT™, an Innovative, New Lapidus Plating System
Forma Medical Inc., a leader in orthopedic Minimally Invasive Surgery (MIS) solutions, today announced the limited market release of OptimalTMT, an innovative MIS Lapidus plating system. OptimalTMT™ builds upon the clinical excellence of OptimalMTP, the MIS MTP fusion plating system, validated by over 200 successful surgeries.
Forma Medical Announces Milestone Achievement: 15th Patient Successfully Treated with OptimalMTP®, the World's First Minimally Invasive Plate and Screw System
Forma Medical Inc., a leader in innovative orthopedic solutions, proudly announces the successful treatment of the 15th patient with its groundbreaking OptimalMTP system. The limited release began in August and has now concluded, Forma will now commence broad commercialization of this revolutionary system. The OptimalMTP system is the world's first minimally invasive plate and screw solution for MIS fusion of the first metatarsophalangeal (MTP) joint.
Forma Medical Granted FDA Clearance For Optimal Plating System Enabling a Multi-Faceted Growth Strategy for MIS Forefoot Portfolio
Forma Medical Inc., a leading innovator in medical device technologies, is thrilled to announce the FDA 510(k) clearance for its groundbreaking OptimalMTP® Plating System. This regulatory milestone marks a significant leap forward in MIS (Minimally Invasive Surgery), ushering in a new era of precision and efficiency dedicated to foot and ankle surgery, one of the fastest growing segments in the medical device space.
